Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

NCT00329082 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Study for Safety and Tolerability of AL002.

NCT03635047 ·Status: COMPLETED ·Phase: PHASE1

A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease

NCT06810960 ·Status: RECRUITING

Safety and Efficacy of AR1005 in Patients with Lewy Body Disease

NCT06537076 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255 ·Status: COMPLETED ·Phase: PHASE2

Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease

NCT00749216 ·Status: COMPLETED ·Phase: PHASE2

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

NCT00606164 ·Status: UNKNOWN ·Phase: PHASE2

The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.

NCT07212062 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

NCT05681819 ·Status: COMPLETED ·Phase: PHASE1

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

NCT00722046 ·Status: COMPLETED ·Phase: PHASE2

A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease

NCT02820896 ·Status: COMPLETED ·Phase: PHASE1

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

NCT03887455 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

NCT05063539 ·Status: COMPLETED ·Phase: PHASE2

A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease

NCT01944436 ·Status: COMPLETED

Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.

NCT01117948 ·Status: TERMINATED ·Phase: PHASE2

12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease

NCT07034222 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

NCT01125631 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects

NCT01221259 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers

NCT05965414 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease

NCT02389413 ·Status: COMPLETED ·Phase: PHASE2

Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients

NCT01485302 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

NCT00948259 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease

NCT06995573 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease

NCT06206824 ·Status: RECRUITING ·Phase: PHASE1

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

NCT00607308 ·Status: COMPLETED ·Phase: PHASE1